NCT01286337已完成3 期
Axillary Lymphadenectomy. A Randomized Trial Comparing Bipolar Vessel Sealing To Conventional Technique
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 116
- 试验地点
- 2
- 主要终点
- reduction of lymphorrhea rate
研究概览
简要总结
lymphorrehea remains the most frequent complication after axillary lymphadenectomy. we hyphothesize that the use of a bipolar vessel sealing may reduce the rate of lymph collection compared to the traditional surgical technique
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women with documented breast cancer (by histology or cytology) and candidate to elective axillary lymphadenectomy
排除标准
- •Age less than 18 years
- •Denied written informed content
- •Previous axillary operations (except for sentinel node biopsy)
- •Preoperative radio-chemotherapy
- •Scheduled reconstructive breast operation
结局指标
主要结局
reduction of lymphorrhea rate
时间窗: forth postoperative day
次要结局
- reduction of lymph output from the axillary drain(forth postoperative days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Suction Drain in Axillary Lymph Node Dissection for Malignant MelanomaMalignant MelanomaNCT04648163Medical University of Graz118
已完成
不适用
Sentinel Node Biopsy in Breast Cancer PatientsRecurrenceBreast CancerNCT01351974Uppsala University3,369
尚未招募
不适用
o Axillary sUrgical Treatment In clinically Lymph node negative patients after UltraSonography[NAUTILUS]: A Prospective, Multicenter, phase III Clinical TrialNeoplasmsKCT0004840Seoul National University Hospital1,734
招募中
不适用
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast CancerChemotherapySentinel Lymph NodeAxillary Lymph Nodes DissectionRadiotherapy Side EffectBreast CancerNCT04889924Hospital Universitari de Bellvitge820
已完成
不适用
Feasibility of Serratus Plane Block Associated With Sedation in Axillary DissectionAnesthesiaRegional Anesthesia MorbidityAxillary MetastasesNerve BlockAnalgesiaSkin CancerNCT03740815Instituto Nacional de Cancer, Brazil15